BioCentury
ARTICLE | Financial News

Adagene raises $50M in series C for antibodies in China

March 30, 2018 3:15 PM UTC

Adagene Inc. (Suzhou, China) raised $50 million in an oversubscribed series C round led by Sequoia China with participation from New World TMT, AVIC Trust, King Star Capital, Gopher Asset Management and other undisclosed investors.

Adagene is using its Dynamic Precision Library (DPL) technology to develop agonist and antagonist therapeutic antibodies. According to the company's website, its lead program is in IND-enabling studies for oncology indications...

BCIQ Company Profiles

Adagene Inc.